Lv1
10 积分 2023-11-30 加入
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
14天前
已完结
FcRn inhibitors: Transformative advances and significant impacts on IgG-mediated autoimmune diseases
14天前
已完结
FcRn inhibitors in immune thrombocytopenia: A comprehensive review of therapeutic advances and clinical outcomes
2个月前
已完结
Daratumumab monotherapy reverses the immune and pro-fibrotic profiles in refractory lupus nephritis patients: a pilot case study
3个月前
已关闭
Neuroimaging standards for research into small vessel disease—advances since 2013
4个月前
已完结
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
6个月前
已完结
Tertiary lymphoid structures in the central nervous system
7个月前
已完结
Formyl peptide receptor 1 and its antagonist T0080 in atherosclerosis
9个月前
已完结
Type I Interferon Signaling Augments Autoimmunity in Neuromyelitis Optica Spectrum Disorder
9个月前
已完结
皖公网安备34019202002308
